CLINICAL_TRIALS
trial_result
· 2025-02-24
Clinical Trial Update: Dermatopharmacokinetic Trial of LEO 80185 Gel [Phase 1]
Summary
Phase 1 dermatopharmacokinetic trial of LEO 80185 Gel completed in psoriasis, evaluating skin pharmacokinetics.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED